COVID-19 Vaccine Associated Thrombocytopenia
Thrombocytopenia is a condition in which there is a lower-than-normal number of platelets in the blood. It may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues.
Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Thrombocytopenia
Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines
Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines
Thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine
Thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19
Post-mortem findings in vaccine-induced thrombotic thrombocytopenia (covid-19)
Vaccine-induced thrombotic thrombocytopenia: the dark chapter of a success story
Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination
Severe and refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccination
Purpuric rash and thrombocytopenia after mRNA-1273 (Modern) COVID-19 vaccine
Thrombosis with thrombocytopenia after messenger RNA vaccine -1273
Exacerbation of immune thrombocytopenia after COVID-19 vaccination
PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia
Antibody epitopes in vaccine-induced immune immune thrombotic thrombocytopenia
Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines
Immune thrombocytopenia associated with Pfizer-BioNTech’s COVID-19 BNT162b2 mRNA vaccine.
Laboratory testing for suspicion of COVID-19 vaccine-induced thrombotic (immune) thrombocytopenia
Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine
Secondary immune thrombocytopenia (ITP) associated with ChAdOx1 Covid-19 vaccine: case report
Thrombocytopenia after COVID-19 vaccination.
Thrombotic thrombocytopenia after vaccination with COVID-19: in search of the underlying mechanism
Thrombosis and SARS-CoV-2 vaccines: vaccine-induced immune thrombotic thrombocytopenia.
Immune complexes, innate immunity and NETosis in ChAdOx1 vaccine-induced thrombocytopenia.
Immune-mediated thrombocytopenic purpura after Pfizer-BioNTech COVID-19 vaccine in an elderly woman
Immune-mediated thrombocytopenia associated with Ad26.COV2.S vaccine (Janssen; Johnson & Johnson).
Immune thrombocytopenia after vaccination during the COVID-19 pandemic
Vaccine-induced thrombocytopenia with severe headache
Thrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination
Vaccine-induced thrombocytopenia with severe headache
ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome
VITT (vaccine-induced immune thrombotic thrombocytopenia) after vaccination with ChAdOx1 nCoV-19
Cerebral venous sinus thrombosis after vaccination: the UK experience
Venous thromboembolism and mild thrombocytopenia after vaccination with ChAdOx1 nCoV-19
COVID-19 vaccine-induced thrombotic thrombocytopenia: a case series
Case report of immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19.
Thrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination
Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
Relapse of immune thrombocytopenia after COVID-19 vaccination
Images of immune thrombotic thrombocytopenia induced by Oxford / AstraZeneca® COVID-19 vaccine.
Complicated case report of long-term vaccine-induced thrombotic immune thrombocytopenia A.
Relapse of immune thrombocytopenia after covid-19 vaccination in young male patient.